200
Views
1
CrossRef citations to date
0
Altmetric
Original Articles

Relationship between advanced glycated end products and maternal cognition in gestational diabetes: a case control study

, , , , &
Pages 7806-7811 | Received 28 Jan 2021, Accepted 28 May 2021, Published online: 21 Jun 2021

References

  • Wong T, Ross GP, Jalaludin BB, et al. The clinical significance of overt diabetes in pregnancy. Diabet Med. 2013;30(4):468–474.
  • Gilmartin ABH, Ural SH, Repke JT. Gestational diabetes mellitus. Rev Obstet Gynecol. 2008;1(3):129–134.
  • International Diabetes Federation. IDF diabetes atlas. 6th ed. Brussels, Belgium: International Diabetes Federation; 2013.
  • Mahalakshmi MM, Bhavadharini B, Maheswari K, et al. Current practices in the diagnosis and management of gestational diabetes mellitus in India (WINGS-5). Indian J Endocrinol Metab. 2016;20(3):364–368.
  • Yuen L, Wong VW. Gestational diabetes mellitus: challenges for different ethnic groups. World J Diabetes. 2015;6(8):1024–1032.
  • John CM, Mohamed YN, Abdul AS, et al. Maternal cognitive impairment associated with gestational diabetes mellitus-a review of potential contributing mechanisms. Int J Mol Sci. 2018;19(12):3894.
  • Spauwen PJJ, van Eupen MGA, Köhler S, et al. Associations of advanced glycation end-products with cognitive functions in individuals with and without type 2 diabetes: the Maastricht study. J Clin Endocrinol Metab. 2015;100(3):951–960.
  • Li S, Yang H. Relationship between advanced glycation end products and gestational diabetes mellitus. J Mater Fetal Neonat Med.2019;32(17):2783–2789.
  • Sisay M, Edessa D, Ali T, et al. The relationship between advanced glycation end products and gestational diabetes: a systematic review and meta-analysis. PLoS One. 2020;15(10):e0240382.
  • International Association of Diabetes and Pregnancy Study Groups Consensus Panel*. International Association of Diabetes and Pregnancy Study Groups recommendations on the diagnosis and classification of hyperglycemia in pregnancy. Diabetes Care. 2010;33(3):676–682.
  • Ng A, Chew I, Narasimhalu K, et al. Effectiveness of Montreal Cognitive Assessment for the diagnosis of mild cognitive impairment and mild Alzheimer’s disease in Singapore. Singapore Med J. 2013;54(11):616–619.
  • Ismail Z, Rajji TK, Shulman KI. Brief cognitive screening instruments: an update. Int J Geriatr Psychiatry. 2010;25(2):111–120.
  • Alagiakrishnan K, Zhao N, Mereu L, et al. Montreal cognitive assessment is superior to standardized mini-mental status exam in detecting mild cognitive impairment in the middle-aged and elderly patients with type 2 diabetes mellitus. Biomed Res Int. 2014;2014:1–2.
  • Nasreddine ZS, Phillips NA, Bédirian V, et al. The Montreal Cognitive Assessment, MoCA: a brief screening tool for mild cognitive impairment. J Am Geriatr Soc. 2005;53(4):695–699.
  • Bhatia T, Shriharsh V, Adlakha S, et al. The trail making test in India. Indian J Psychiatry. 2007;49(2):113–116.
  • Mitrushina MN, Boone KB, D'Elia LF. Trail making test. In: Handbook of normative data for neuropsychological assessment, 2nd ed. New York: Oxford University Press; 1999.p. 59–98.
  • Egerházi A, Glaub T, Balla P, et al. P300 in mild cognitive impairment and in dementia. Psychiatr Hung Magy Pszichiatriai Tarsasag Tudomanyos Folyoirata. 2008;23(5):349–357.
  • Van Dinteren R, Arns M, Jongsma MLA, et al. P300 development across the lifespan: a systematic review and meta-analysis. PLOS One. 2014;9(2):e87347.
  • Nowotny K, Jung T, Höhn A, et al. Advanced glycation end products and oxidative stress in type 2 diabetes mellitus. Biomolecules. 2015;5(1):194–222.
  • Yaffe K, Lindquist K, Schwartz AV, et al. Advanced glycation end product level, diabetes, and accelerated cognitive aging. Neurology. 2011;77(14):1351–1356.
  • West RK, Moshier E, Lubitz I, et al. Dietary advanced glycation end products are associated with decline in memory in young elderly. Mech Ageing Dev. 2014;140:10–12.
  • Stites SD, Harkins K, Rubright JD, et al. Relationships between cognitive complaints and quality of life in older adults with mild cognitive impairment, mild Alzheimer disease dementia, and normal cognition. Alzheimer Dis Assoc Disord. 2018;32(4):276–283.
  • Davies SJ, Lum JA, Skouteris H, et al. Cognitive impairment during pregnancy: a meta-analysis. Med J Aust. 2018;208(1):35–40.
  • Liu YHai, Han JYin, Ning L, et al. Cognitive function and life quality of patients with moderate-to-severe obstructive sleep apnea-hypopnea syndrome in China. Expert Rev Respirat Med. 2021;15(3):435–440.
  • Ahmed T;T1, Kumar R, Bahurupi Y, TamannaFactors Affecting Quality of Life among Post-Stroke Patients in the Sub-Himalayan Region. J Neurosci Rural Pract. 2020;11(04):616–622.
  • Pattanayak RD, Sagar R, Mehta M. Neuropsychological performance in euthymic Indian patients with bipolar disorder type I: correlation between quality of life and global functioning. Psychiatry Clin Neurosci. 2012;66(7):553–563.
  • Alagiakrishnan K, Zhao N, Mereu L, et al. Montreal Cognitive Assessment is superior to Standardized Mini-Mental Status Exam in detecting mild cognitive impairment in the middle-aged and elderly patients with type 2 diabetes mellitus. Biomed Res Int. 2013;2013:186106.
  • Suresh KP, Greeshma C, Sreekumaran E. Study of dementia in diabetic patients with particular reference to Cerad and Trail Making Test. Int J Sci Eng Res. 2014;5(10):74–77.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.